Risk Factors for Alzheimer Disease Linked to Cognitive Function Before Midlife
By Elana Gotkine HealthDay Reporter
THURSDAY, May 1, 2025 -- Risk factors for Alzheimer disease are associated with cognitive function starting in the mid-20s, according to a study published in the May issue of The Lancet Regional Health: Americas.
Allison E. Aiello, Ph.D., from Columbia University in New York City, and colleagues analyzed data from the National Longitudinal Study of Adolescent to Adult Health (Add Health). Participants were enrolled in grades 7 to 12 in 1994 to 1995 and followed through 2018. Weighted survey and biomarker data from waves IV (age 26 to 29 years) and V (age 36 to 39 years) were analyzed cross-sectionally. The Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) score, composed of age, education, sex, systolic blood pressure, body mass index, cholesterol, and physical activity and apolipoprotein E ε4 allele status, was measured, as were various blood biomarkers.
The researchers found that the CAIDE score was associated with all cognition measures in wave IV. For example, each 1-point increase in CAIDE was associated with a 0.03 standard deviation lower backward digit score among adults aged 24 to 34 years. There was an association for total Tau with immediate word recall in wave V (β = −0.13). Associations were also seen for wave IV high-sensitivity C-reactive protein and interleukin (IL)-10 and wave V IL-6, IL-1β, and IL-8 with lower cognition scores.
"The potential impact of our findings is substantial, offering clinicians and health researchers a clearer understanding of the early emergence of Alzheimer disease risk factors and their association with cognition before middle age," Aiello said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors
MONDAY, June 30, 2025 -- Breast cancer survivors have a lower risk of Alzheimer disease (AD) compared with cancer-free controls, according to a study published online June 20 in...
Late-Life Mood Disorders May Indicate Predisposition to Dementia
MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9...
Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease
MONDAY, June 30, 2025 -- For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the triglyceride-glucose (TyG)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.